167 related articles for article (PubMed ID: 10213225)
1. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M; Takechi T; Okabe H; Fukushima M
Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
[TBL] [Abstract][Full Text] [Related]
2. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.
Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Renée N; Milano G
Eur J Cancer; 1994; 30A(10):1517-22. PubMed ID: 7833111
[TBL] [Abstract][Full Text] [Related]
3. Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review).
Milano G; Etienne MC
Anticancer Res; 1994; 14(6A):2295-7. PubMed ID: 7825962
[TBL] [Abstract][Full Text] [Related]
4. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.
Etienne MC; Chéradame S; Fischel JL; Formento P; Dassonville O; Renée N; Schneider M; Thyss A; Demard F; Milano G
J Clin Oncol; 1995 Jul; 13(7):1663-70. PubMed ID: 7602356
[TBL] [Abstract][Full Text] [Related]
5. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
Johnston PG; Drake JC; Trepel J; Allegra CJ
Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
[TBL] [Abstract][Full Text] [Related]
6. [Dihydropyrimidine dehydrogenase activity in lymphocytes: predictive factor for 5-fluorouracil clearance].
Etienne MC; Milano G; Fleming RA; Thyss A; Renée N; Schneider M; Demard F
Bull Cancer; 1992; 79(12):1159-63. PubMed ID: 1304835
[TBL] [Abstract][Full Text] [Related]
7. Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.
Fleming RA; Milano G; Thyss A; Etienne MC; Renée N; Schneider M; Demard F
Cancer Res; 1992 May; 52(10):2899-902. PubMed ID: 1581906
[TBL] [Abstract][Full Text] [Related]
8. Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer.
Kornmann M; Link KH; Galuba I; Ott K; Schwabe W; Häusler P; Scholz P; Sträter J; Polat S; Leibl B; Kettner E; Schlichting C; Baumann W; Schramm H; Hecker U; Ridwelski K; Vogt JH; Zerbian KU; Schütze F; Kreuser ED; Behnke D; Beger HG
J Gastrointest Surg; 2002; 6(3):331-7. PubMed ID: 12022983
[TBL] [Abstract][Full Text] [Related]
9. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
[TBL] [Abstract][Full Text] [Related]
10. [The significance of measuring inhibition of thymidylate synthase activity as a parameter for antitumor activity of 5-fluorouracil derivatives].
Takeda S; Uchida J; Yamada Y; Unemi N; Fujii S
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2125-30. PubMed ID: 3395138
[TBL] [Abstract][Full Text] [Related]
11. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T
Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic aspects of in vitro and in vivo chemosensitivity tests.
Isobe Y; Kubota T; Asanuma F; Kurihara H; Inada T; Fukutomi T; Ishibiki K; Abe O
Jpn J Cancer Res; 1987 Sep; 78(9):983-90. PubMed ID: 3117754
[TBL] [Abstract][Full Text] [Related]
13. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors.
Van der Wilt CL; Pinedo HM; Smid K; Peters GJ
Cancer Res; 1992 Sep; 52(18):4922-8. PubMed ID: 1516048
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice].
Shirasaka T; Fujita F; Fujita M; Fukushima M; Taguchi T; Fujii S
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1871-6. PubMed ID: 2393305
[TBL] [Abstract][Full Text] [Related]
15. Cell kinetics and chemosensitivity of human carcinomas serially transplanted into nude mice.
Kubota T; Nakada M; Tsuyuki K; Inada T; Asanuma F; Ishibiki K; Abe O
Jpn J Cancer Res; 1986 May; 77(5):502-7. PubMed ID: 3089982
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on the clonogenic assay--in vitro and in vivo chemosensitivity tests of human tumor xenografts serially transplanted into nude mice].
Kubota T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1201-7. PubMed ID: 3729442
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil treatment of a human colon adenocarcinoma implanted in the subrenal capsule site of athymic mice.
Zimmerman RJ; VanWinkle TJ; Mantel N; Frei E; Goldin A
Cancer Res; 1986 Feb; 46(2):694-700. PubMed ID: 3940636
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of human tumor xenografts in genetically athymic mice.
Ovejera AA; Houchens DP; Barker AD
Ann Clin Lab Sci; 1978; 8(1):50-6. PubMed ID: 623430
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor activity of cisplatin and carboplatin against human tumor xenografts serially transplanted into nude mice--with special reference to gastric carcinomas].
Shimoyama Y; Kubota T; Inoue S; Kuzuoka M; Ohishi T; Oka S; Kikuyama S; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2682-7. PubMed ID: 3307633
[TBL] [Abstract][Full Text] [Related]
20. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]